Press "Enter" to skip to content

Officials within the FDA were stunned by the news that Drs. Gruber and Krause were leaving the agency

Two senior leaders in the US Food and Drug Administration’s vaccine review office are stepping down, even as the agency works toward high-profile decisions around Covid-19 vaccine approvals, authorizations for younger children and booster shots.

Two senior leaders in the US Food and Drug Administration’s vaccine review office are stepping down, even as the agency works toward high-profile decisions around Covid-19 vaccine approvals, authorizations for younger children and booster shots.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *